Purinergic (P2Y) Receptors

5 个项目

每页

设置升序顺序
  1. Cangrelor Tetrasodium

    Catalog No. A17919
    Quick View
    P2Y12 receptors inhibitor
    Cangrelor Tetrasodium is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. 了解更多
  2. Vicagrel

    Catalog No. A18586
    Quick View
    P2Y12 platelet inhibitor
    Vicagrel, an acetate derivative of Clopidogrel, is a P2Y12 platelet inhibitor potentially for the treatment of thrombosis. 了解更多
  3. Clopidogrel thiolactone

    Catalog No. A20862
    Quick View
    P2Y12 receptor inhibitor
    Clopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent. 了解更多
  4. Prasugrel (Effient)

    Catalog No. A10748
    Quick View
    platelet inhibitor
    Prasugrel (Effient)是一种新型的血小板抑制剂,用于减少急性冠脉综合征(PCI)患者的血栓性心血管事件(包括支架血栓形成)。 了解更多
  5. Clopidogrel

    Catalog No. A21206
    Quick View
    platelet inhibitor
    Clopidogrel is a well-known and orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. 了解更多

5 个项目

每页

设置升序顺序
Rewards